Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Specialized Stain Enables Exceptional Bone Marrow Diagnostic Pathology

By LabMedica International staff writers
Posted on 13 Mar 2014
A new tissue stain has been specially developed to provide superior clarity of differentiation and detail in bone marrow tissue samples for disease diagnosis. More...


Dako (Glostrup, Denmark), an Agilent Technologies (Santa Clara, CA, USA) company, has now added its new Jenner-Wright Giemsa stain to Dako's broad palette of automated stains – its Artisan Link portfolio. Dako is releasing the stain in its continuing mission to provide pathology labs with the most advanced special stain solutions and the broadest portfolio.

The Jenner-Wright Giemsa stain is designed to give pathologists an added dimension to the visualization of the cell morphology by providing clear differentiation and detail of hematopoietic cells in bone marrow samples for the diagnosis of diseases, such as cancer, aplastic anemia, and myelofibrosis.

The Artisan portfolio provides the broadest range of automated special stains available—currently consisting of 31 high-quality stains, covering most of a typical laboratory’s special stain needs. Dako also plans to add more stains to the portfolio.

The portfolio also enables labs to take advantage of the productivity benefits possible through automation with the Artisan Link Pro instrument. Laboratories that routinely do special stains will benefit from a 64% reduction in hands-on time with Artisan Link Pro, compared with the same protocols performed manually. Significant gains in lab safety can be realized because the Artisan Link Pro and its ready-to-use reagents are closed, minimizing exposure to hazardous chemicals, and can be connected to ventilation systems. The instrument also features a unique waste separation system that reduces hazardous waste generation, helping labs minimize disposal and associated costs.

"Dako’s Jenner-Wright Giemsa special stain for bone marrow is excellent, and allows us, for the first time, to automate the diagnosis of various diseases using bone marrow tissue," said Prof. Hermann Herbst, director of the Vivantes Pathology Department in Berlin. "Artisan Link Pro stains are fabulous to look at. This stain in particular offers an unprecedented ability to use bone marrow and provides exceptionally clear differentiation and detail."

Related Links:

Dako
Dako's Jenner-Wright Giemsa kit
Agilent Technologies 



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.